Ipca Laboratories Limited Ipca Laboratories Limited

Ipca Laboratories Limited

IPCALAB

株式のランク #3403
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
株価
$20.02
最終同期: 2026-10-19
時価総額
$5.08B
変化(1日)
-1.65%
変化(1年)
38.46%
国
IN
取引 Ipca Laboratories Limited (IPCALAB)

カテゴリー

Healthcare
Ipca Laboratories Limited(IPCALAB)の配当利回りの履歴
Ipca Laboratories Limited(銘柄コード: IPCALAB)の配当利回り(TTM)は2024-03-31時点で0.16%です。
過去5年間の平均配当利回り: 0.35%
Ipca Laboratories Limited(IPCALAB)の2005から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
年 配当利回り 変化
2026 (TTM) 0.31% 6.90%
2025 0.29% 81.25%
2024 0.16% -67.35%
2023 0.49% 28.95%
2022 0.38% -9.52%
2021 0.42% -39.13%
2020 0.69% 430.77%
2019 0.13% -27.78%
2018 0.18% 0.00%
2017 0.00% -100.00%
2016 0.21% -54.35%
2015 0.46% -25.81%
2014 0.62% -11.43%
2013 0.70% -36.36%
2012 1.10% -5.17%
2011 1.16% 2.65%
2010 1.13% -72.10%
2009 4.05% 185.21%
2008 1.42% 15.45%
2007 1.23% -31.28%
2006 1.79% -13.11%
2005 2.06% 0.00%
類似企業または競合他社の配当利回り(TTM)